Archives of Plastic Surgery, Table of Contents CC BY-NC 4.0 · Arch Plast Surg 2012; 39(05): 565-574DOI: 10.5999/aps.2012.39.5.565 Continuing Medical Education Management of Malignant Melanoma Goo-Hyun Mun Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea › Author Affiliations Recommend Article Abstract Full Text References REFERENCES 1 Sneyd M, Cox B. The control of melanoma in New Zealand. N Z Med J 2006; 119: U2169 2 Parkin DM, Bray F, Ferlay J. et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108 3 Jemal A, Siegel R, Ward E. et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249 4 Lea CS, Scotto JA, Buffler PA. et al. Ambient UVB and melanoma risk in the United States: a case-control analysis. Ann Epidemiol 2007; 17: 447-453 5 Green A, McCredie M, MacKie R. et al. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control 1999; 10: 21-25 6 Netscher DT, Leong M, Orengo I. et al. Cutaneous malignancies: melanoma and nonmelanoma types. Plast Reconstr Surg 2011; 127: 37e-56e 7 Lederman JS, Sober AJ. Does biopsy type influence survival in clinical stage I cutaneous melanoma?. J Am Acad Dermatol 1985; 13: 983-987 8 Martin 2nd RC, Scoggins CR, Ross MI. et al. Is incisional biopsy of melanoma harmful?. Am J Surg 2005; 190: 913-917 9 Bong JL, Herd RM, Hunter JA. Incisional biopsy and melanoma prognosis. J Am Acad Dermatol 2002; 46: 690-694 10 Lees VC, Briggs JC. Effect of initial biopsy procedure on prognosis in Stage 1 invasive cutaneous malignant melanoma: review of 1,086 patients. Br J Surg 1991; 78: 1108-1110 11 Griffiths RW, Briggs JC. Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma. Ann R Coll Surg Engl 1986; 68: 58 12 Molenkamp BG, Sluijter BJ, Oosterhof B. et al. Non-radical diagnostic biopsies do not negatively influence melanoma patient survival. Ann Surg Oncol 2007; 14: 1424-1430 13 Stell VH, Norton HJ, Smith KS. et al. Method of biopsy and incidence of positive margins in primary melanoma. Ann Surg Oncol 2007; 14: 893-898 14 Karimipour DJ, Schwartz JL, Wang TS. et al. Microstaging accuracy after subtotal incisional biopsy of cutaneous melanoma. J Am Acad Dermatol 2005; 52: 798-802 15 Austin JR, Byers RM, Brown WD. et al. Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck. Head Neck 1996; 18: 107-117 16 Ng JC, Swain S, Dowling JP. et al. The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service. Arch Dermatol 2010; 146: 234-239 17 Ng PC, Barzilai DA, Ismail SA. et al. Evaluating invasive cutaneous melanoma: is the initial biopsy representative of the final depth?. J Am Acad Dermatol 2003; 48: 420-424 18 Pflugfelder A, Weide B, Eigentler TK. et al. Incisional biopsy and melanoma prognosis: Facts and controversies. Clin Dermatol 2010; 28: 316-318 19 Lorusso GD, Sarma DP, Sarwar SF. Punch biopsies of melanoma: a diagnostic peril. Dermatol Online J 2005; 11: 7 20 Bichakjian CK, Halpern AC, Johnson TM. et al. Guidelines of care for the management of primary cutaneous melanoma American Academy of Dermatology J Am Acad Dermatol. 2011; 65: 1032-1047 21 Balch CM, Gershenwald JE, Soong SJ. et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-6206 22 Lens MB, Nathan P, Bataille V. Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials. Arch Surg 2007; 142: 885-891 23 Chang JW. Cutaneous melanoma: Taiwan experience and literature review. Chang Gung Med J 2010; 33: 602-612 24 Wright F, Spithoff K, Easson A. et al. Primary excision margins and sentinel lymph node biopsy in clinically node-negative melanoma of the trunk or extremities. Clin Oncol (R Coll Radiol) 2011; 23: 572-578 25 Parrett BM, Kashani-Sabet M, Singer MI. et al. Long-term prognosis and significance of the sentinel lymph node in head and neck melanoma. Otolaryngol Head Neck Surg 04/2012; 24 [Epub] 26 Jahn V, Breuninger H, Garbe C. et al. Melanoma of the ear: prognostic factors and surgical strategies. Br J Dermatol 2006; 154: 310-318 27 Kozlow JH, Rees RS. Surgical management of primary disease. Clin Plast Surg 2010; 37: 65-71 28 Wagner A, Garrido I, Ferron G. et al. Subungual melanoma: for a conservative approach on the thumb scale. Ann Plast Surg 2007; 59: 344-348 29 Morton DL, Wen DR, Wong JH. et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399 30 Morton DL, Thompson JF, Essner R. et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial Multicenter Selective Lymphadenectomy Trial Group Ann Surg. 1999; 230: 453-463 31 Reintgen D, Cruse CW, Wells K. et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220: 759-767 32 Mattsson J, Bergkvist L, Abdiu A. et al. Sentinel node biopsy in malignant melanoma: Swedish experiences 1997-2005. Acta Oncol 2008; 47: 1519-1525 33 Rossi CR, De Salvo GL, Trifiro G. et al. The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI). J Nucl Med 2006; 47: 234-241 34 Twomey P. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-1, an international multicenter trial. Ann Surg 2007; 245: 156-157 35 Gershenwald JE, Mansfield PF, Lee JE. et al. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (≥4 mm) primary melanoma. Ann Surg Oncol 2000; 7: 160-165 36 Ferrone CR, Panageas KS, Busam K. et al. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol 2002; 9: 637-645 37 Bleicher RJ, Essner R, Foshag LJ. et al. Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. J Clin Oncol 2003; 21: 1326-1331 38 Warycha MA, Zakrzewski J, Ni Q. et al. Meta-analysis of sentinel lymph node positivity in thin melanoma (≤1 mm). Cancer 2009; 115: 869-879 39 Wright BE, Scheri RP, Ye X. et al. Importance of sentinel lymph node biopsy in patients with thin melanoma. Arch Surg 2008; 143: 892-899 40 Phan GQ, Messina JL, Sondak VK. et al. Sentinel lymph node biopsy for melanoma: indications and rationale. Cancer Control 2009; 16: 234-239 41 Tagawa ST, Cheung E, Banta W. et al. Survival analysis after resection of metastatic disease followed by peptide vaccines in patients with Stage IV melanoma. Cancer 2006; 106: 1353-1357 42 Balch CM, Soong SJ, Gershenwald JE. et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622-3634 43 Lui P, Cashin R, Machado M. et al. Treatments for metastatic melanoma: synthesis of evidence from randomized trials. Cancer Treat Rev 2007; 33: 665-680 44 Testori A, Rutkowski P, Marsden J. et al. Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol 2009; 20 (Suppl. 06) vi22-vi29 45 Dong XD, Tyler D, Johnson JL. et al. Analysis of prognosis and disease progression after local recurrence of melanoma. Cancer 2000; 88: 1063-1071 46 Storm FK, Sparks FC, Morton DL. Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guerin and hyperthermic perfusion. Surg Gynecol Obstet 1979; 149: 17-21 47 Testori A, Richards J, Whitman E. et al. Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group. J Clin Oncol 2008; 26: 955-962 48 Sutherland CM, Mather FJ, Krementz ET. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion. Surg Gynecol Obstet 1987; 164: 111-118 49 Francken AB, Accortt NA, Shaw HM. et al. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma. Ann Surg Oncol 2008; 15: 1476-1484 50 Balch CM, Urist MM, Karakousis CP. et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg 1993; 218: 262-267 51 Karakousis CP, Balch CM, Urist MM. et al. Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol 1996; 3: 446-452 52 Mooney MM, Mettlin C, Michalek AM. et al. Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences: a cost-effectiveness analysis. Cancer 1997; 80: 1052-1064 53 Cohn-Cedermark G, Rutqvist LE, Andersson R. et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm. Cancer 2000; 89: 1495-1501 54 Gow KW, Rapkin LB, Olson TA. et al. Sentinel lymph node biopsy in the pediatric population. J Pediatr Surg 2008; 43: 2193-2198 55 Strouse JJ, Fears TR, Tucker MA. et al. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 2005; 23: 4735-4741 56 Raval MV, Bilimoria KY, Bentrem DJ. et al. Use of sentinel lymph node biopsy for melanoma in children and adolescents. J Surg Oncol 2010; 102: 634-639 57 Melnik MK, Urdaneta LF, Al-Jurf AS. et al. Malignant melanoma in childhood and adolescence. Am Surg 1986; 52: 142-147 58 Shah NC, Gerstle JT, Stuart M. et al. Use of sentinel lymph node biopsy and high-dose interferon in pediatric patients with high-risk melanoma: the Hospital for Sick Children experience. J Pediatr Hematol Oncol 2006; 28: 496-500
